| Characteristics | Number | % |
| Age (years) Median (range) | 48 (21 - 67) |
|
| Sex Male Female |
82 57 |
59% 41% |
| ECOG PS 0 1 2 |
40 74 25 |
28.8% 53.2% 18% |
| Number of extra-nodal sites 0 1 2 |
63 57 19 |
45.3% 41% 13.7% |
| Stage 1 2 3 4 |
4 41 63 31 |
2.9% 29.5% 45.3% 22.3% |
| IPI 0 1 2 3 4 5 |
15 20 40 55 8 1 |
10.8% 14.4% 28.8% 39.6% 5.8% 0.7% |
| Treatment R-CHOP CHOP |
35 104 |
25.2% 74.8% |
| Following the completion of therapy Median (Range). Absolute lymphocyte count Absolute monocyte count Lymphocyte Monocyte ratio |
1290 (770 - 1870) 390 (200 - 680) 3.8 (1.3 - 6) |
|
| LDH following completion of therapy Normal >Normal |
91 48 |
65.5% 34.5% |
| State of disease Free (not relapsed) Relapsed |
100 39 |
71.9% 28.1% |